Roivant Sciences Ltd. (ROIV) Misses Q3 EPS by 7c
Tweet
Share
E-mail
Get Alerts ROIV Hot Sheet
Join SI Premium – FREE
Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q3 EPS of ($0.38), $0.07 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $1.99 million versus the consensus estimate of $5.13 million.
For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E Corp, Edison spike on chatter
- Apple new CEO Ternus teases "phenomenal" iPhone launch in first memo
- LP Building Solutions to halt OSB output at Texas plant in October
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
